Does EFALIZUMAB Cause Progressive multifocal leukoencephalopathy? 10 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Progressive multifocal leukoencephalopathy have been filed in association with EFALIZUMAB. This represents 4.4% of all adverse event reports for EFALIZUMAB.
10
Reports of Progressive multifocal leukoencephalopathy with EFALIZUMAB
4.4%
of all EFALIZUMAB reports
1
Deaths
9
Hospitalizations
How Dangerous Is Progressive multifocal leukoencephalopathy From EFALIZUMAB?
Of the 10 reports, 1 (10.0%) resulted in death, 9 (90.0%) required hospitalization.
Is Progressive multifocal leukoencephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EFALIZUMAB. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does EFALIZUMAB Cause?
Death (56)
Psoriasis (55)
Pruritus (35)
Erythema (28)
Drug ineffective (26)
Pain (25)
Decreased appetite (24)
Hypersensitivity (24)
Vomiting (24)
Nausea (23)
What Other Drugs Cause Progressive multifocal leukoencephalopathy?
NATALIZUMAB (1,668)
RITUXIMAB (1,647)
CYCLOPHOSPHAMIDE (782)
PREDNISONE (606)
PREDNISOLONE (439)
TACROLIMUS (438)
METHOTREXATE (428)
DOXORUBICIN (421)
MYCOPHENOLATE MOFETIL (414)
VINCRISTINE (376)
Which EFALIZUMAB Alternatives Have Lower Progressive multifocal leukoencephalopathy Risk?
EFALIZUMAB vs EFANESOCTOCOG ALFA
EFALIZUMAB vs EFAVIRENZ
EFALIZUMAB vs EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL
EFALIZUMAB vs EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL
EFALIZUMAB vs EFFEXOR